This blog is where we share stories, announcements, and insights from around the iGEM community.
All tagged Policy
Reflections from the OECD Multistakeholder Consultation on Responsible Innovation and Anticipatory Governance of Emerging Biotechnologies.
Inside iGEM we have a strict Do Not Release policy that keeps our projects inside the lab. If these projects are ever going to be part of real-world solutions then – sooner or later – they will need to work outside of the lab. In 2021, we are substantially increasing the time and effort we devote to considering how to do that safely, securely, and responsibly.
In 2016, iGEM Foundation started the After iGEM Delegate Program, for iGEMers to engage in the international policy dialogue on synthetic biology, experience the setting, and learn about treaties and protocols which influence how scientists conduct, share, access, and support research.
The crisis was completely fictional, but the responses necessary for developing clear containment and communication strategies to address that crisis were real. And the insights, knowledge and training shared at that conference are prescient as we face the global COVID-19 pandemic today.
